PALISADE BIO, INC. — Director's Dealing 2023

Sep 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2023-09-14

Reporting Person: Trenschel Robert J. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-14	Common Stock, par value $0.01	S	300	$0.64	Disposed	0	Direct

Footnotes

F1: Reflects the weighted average sale price. The range of prices for such transaction was $0.6396 to $0.6507. Open market sale transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.